A detailed history of Capital Advisors, Ltd. LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 8 shares of GH stock, worth $261. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$261
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$16.07 - $31.84 $128 - $254
8 New
8 $0
Q3 2022

Nov 09, 2022

BUY
$43.66 - $61.0 $1,746 - $2,440
40 New
40 $2,000
Q1 2022

May 09, 2022

SELL
$48.25 - $100.49 $48 - $100
-1 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$88.71 - $120.43 $88 - $120
1 New
1 $0

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.